Live News Categoriesmarket

BDRX.O (BDRX.O) News

Follow BDRX.O (BDRX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BDRX.O Asset market Sector Markets 90 days 1 Updated Oct 13, 2026, 12:32 PM UTC Open live news feed

L Biodexa enrolls 100th patient in Serenta Phase 3 eRapa trial in familial adenomatous polyposis Biodexa reached 100 enrolled patients in the Serenta registrational Phase 3 trial of eRapa in familial adenomatous polyposis. No trial results were presented; the next readout is a pre-specified futility analysis expecte NEWS | Oct 13, 2026, 12:32 PM UTC